Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and rubidium

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with rubidium in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(rubidium)		Trials
(rubidium)		Recent Studies (post-2010) (rubidium)
9,1561875525,16318269

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, R; Cockeran, R; Steel, HC1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and rubidium

ArticleYear
Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2002, Volume: 110, Issue:2

    Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Inflammation Mediators; Lysophosphatidylcholines; Platelet Activating Factor; Potassium; Rubidium

2002